US Patent Issued to JBKLAB on Nov. 11 for "Immunity-boosting agent, immuno-therapeutic anti-cancer agent, and anti-cancer therapy adverse effect mitigating agent containing anthocyanin-fucoidan complex as active ingredient" (South Korean Inventor)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,627, issued on Nov. 11, was assigned to JBKLAB Co. LTD. (Seongnam-si, South Korea).

"Immunity-boosting agent, immuno-therapeutic anti-cancer agent, and anti-cancer therapy adverse effect mitigating agent containing anthocyanin-fucoidan complex as active ingredient" was invented by Bong Keun Jang (Yongin-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition including an anthocyanin-fucoidan complex formed by ionic bond between anthocyanin and fucoidan as an active ingredient, and more particularly, it is confirmed that the anthocyanin-fucoidan complex in which anion of the fucoidan, which is a n...